Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	1473.76	69.90	-4.44
Graham Fair Price	41.42	0.93	0.66
PEG	94.62	< 0.005	-0.18
Price/Book	-23.91	0.21	0.27
Price/Cash Flow	1.48	-16.98	-17.23
Prices/Earnings	61.96	-0.97	-2.55
Price/Sales	-62.35	9.94	26.40
Price/FCF	1.48	-16.98	-17.23
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	1.69	0.90	0.89
Operating Margin	0.54	0.66	0.66
ROA	-100.00	-0.03	-0.01
ROE	-0.03	-0.05	-100.00
ROIC	< 0.005	< 0.005	6.18
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	-1.00	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.47	1.03	121.48
EPS QOQ	-0.14	-1.00	-606.70
FCF QOQ	-0.91	0.23	-75.04
Revenue QOQ	-0.43	1.02	135.57
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.28	100.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.00	0.48	100.00
Quick Ratio	0.00	0.14	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.85	0.85	< 0.005
Cash	0.11	0.11	< 0.005
Capex	0.00	0.00	0.00
Free Cash Flow	-0.01	-0.01	22.77
Revenue	< 0.005	0.02	102.08
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.00	0.14	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.03	55.34	1274.10
Naive Interpretation	Member

06 - Financial Health · Bad

Rating